Biotech Series B Investors & VC Firms
900 firms in this list, with a median first check of $550K. 188 of them lead rounds. Generated from verified public data and updated continuously.
NGN Capital
New YorkSeries A–Late Stage
6 people
Radar Ventures
Pre-Seed–Growth
Heron Capital
IndianapolisSeries A–Late Stage$10M
5 people
NYVC Ventures
New YorkPre-Seed–Series B
5 people
Alpina Partners
MunichSeries A–Late Stage$635K – $2.5M
2 people
Aditum Bio
OaklandSeries A–Series B
4 people
Build Ventures
HalifaxSeed–Series C
4 people
Black Marble Capital Management
TaipeiSeed–Late Stage
12 people
Diamond Biofund
TaipeiSeed–Series B
6 people
dsm-firmenich Venturing
MaastrichtPre-Seed–Late Stage$108K – $5.4M
9 people
Empire State Development – New York Ventures
New YorkPre-Seed–Series B$500K – $1.5M
9 people
Matū
AucklandPre-Seed–Growth
SBI Investment Korea Co. Ltd.
SeoulSeed–Late Stage$2.5M – $33M
SBI JI Innovation Advisory Ltd.
Tel Aviv-YafoSeed–Series B
6 people
SODENA
PamplonaSeed–Series B$108K
3 people
Zen11 Holding
GrazSeries A–Growth
Oost NL
ApeldoornSeed–Late Stage$108K – $5.4M
2 people
EFung Capital
ShenzhenSeed–Growth
GenerationS
MoscowSeed–Growth
Sanara Capital
Ra'ananaSeed–Late Stage
1 person
T. Rowe Price
BaltimoreSeed–Late Stage
1 person
Stone Bridge Ventures
SeoulSeed–Late Stage$1.4M – $19M
Xerys
ParisSeed–Late Stage$16M – $97M
Serendipity Impact VC
New YorkPre-Seed–Series B
5 people
Related lists
Series B Investors & VC Firms (4094)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Series B Investors & VC Firms in United States (1625)Biotech Series A Investors & VC Firms (1596)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)Healthtech Series B Investors & VC Firms (1216)Fintech Series B Investors & VC Firms (1141)
Data sourced from public filings and firms' own websites — see our methodology.



















